Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations - Margetic, S; Celap, I; Delic Brkljacic, D (Biochem Med (Zagreb), 2020)
et al.